Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

138

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	47,925,322 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg/250ml	400mg/250ml	Injectable solution	9,052,935 L.L
J01MA14	MOFLOXINE	G	Moxifloxacin (HCl) - 400mg/250ml	400mg/250ml	Injectable solution	1,638,144 L.L
V03AF01	UROMITEXAN	B	Mesna - 400mg/4ml	400mg/4ml	Injectable solution	2,632,587 L.L
V03AF01	UROMITEXAN	B	Mesna - 400mg	400mg/4ml	Injectable solution	2,632,587 L.L
A06AD04	EPSOM SALT	G	Magnesium sulfate - 40g	40g	Granules	89,590 L.L
S01EE04	TRAVOPROST BIOGARAN	G	Travoprost - 40mcg/ml	40mcg/ml	Drops solution	564,414 L.L
A02BA03	FAMODAR 40	G	Famotidine - 40mg	40mg	Tablet, film coated	552,319 L.L
A02BA03	FAMONOR	G	Famotidine - 40mg	40mg	Tablet, film coated	439,436 L.L
L01XX74	WELIREG	B	Belzutifan - 40mg	40mg	Tablet, film coated	1,550,772,301 L.L
C03CA01	LASIX	B	Furosemide - 40mg	40mg	Tablet	120,946 L.L
C03CA01	APO-FUROSEMIDE	G	Furosemide - 40mg	40mg	Tablet, scored	862,747 L.L
C03CA01	BIOLASOMIDE	G	Furosemide - 40mg	40mg	Tablet	181,419 L.L
C03CA01	DIURESAL	G	Furosemide - 40mg	40mg	Tablet, scored	118,258 L.L
C03CA01	FURESIX 40	G	Furosemide - 40mg	40mg	Tablet	166,381 L.L
C03CA01	FUROSETIC	G	Furosemide - 40mg	40mg	Tablet, scored	121,586 L.L
C10AA05	APO-ATORVASTATIN	G	Atorvastatin (calcium) - 40mg	40mg	Tablet	1,405,390 L.L
C10AA05	ASCOVA	G	Atorvastatin (calcium) - 40mg	40mg	Tablet	1,612,611 L.L
C10AA05	ATOR MEDIS	G	Atorvastatin - 40mg	40mg	Tablet, film coated	694,767 L.L
C10AA05	ATORLIP 40	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	1,484,626 L.L
C10AA05	ATORVA TAD	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,405,659 L.L
C10AA05	ATORVASTATINE ARROW GENERQUES	G	Atorvastatin - 40mg	40mg	Tablet, coated	564,414 L.L
L02BB04	XTANDI	B	Enzalutamide - 40mg	40mg	Capsule, soft	278,248,827 L.L
C10AA05	ATORVASTATINE ARROW GENERQUES	G	Atorvastatin - 40mg	40mg	Tablet, coated	564,414 L.L
L02BB04	ENZASTIK 40	G	Enzalutamide - 40mg	40mg	Capsule	82,838,963 L.L
C10AA05	EMITOR	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,060,292 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 40mg	40mg	Capsule, hard, gastro-resistant	503,941 L.L
C10AA05	JOSWE ATORVAST 40	G	Atorvastatin - 40mg	40mg	Caplet, film coated	1,327,716 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 40mg	40mg	Capsule, hard, gastro-resistant	956,816 L.L
C10AA05	LIPODAR	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	2,412,197 L.L

...

138

...